TM
Thomas Malley (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $5.9M of KNSA (177,769 sh across 3 lots, as filed), executed Aug 12 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.9M
shares × price, as filed
Last traded
Aug 14 2025
Filed Aug 14 2025
Median ADV $60.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
KNSARecent filings
KNSASALE
Kiniksa Pharmaceuticals International, plc
View filing →
$5.9M177,769 sh across 3 lots
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET